Better Home & Finance shareholders voted to reconstitute the board in favor of founder Vishal Garg, removing five directors including the interim CEO. Egan-Jones supported this move, citing Better's strong performance under Garg and unclear board processes in his removal. The company's stock fell sharply after Garg's ousting, but the new board aims to leverage his strategic expertise as they settle permanent leadership. The focus now shifts from governance disputes to executing the company's strategy.
Better Home & Finance shareholder decisions provide context for Pluang's Financials sector snapshot as of Oct 28, 2026 23:02 WIB: Among 142 priced US Financials stocks, 65 rose and 72 fell. Banco Bradesco (BBD) dropped 4.98% with 73% of Pluang orders selling, contrasting with Banco Santander Brasil (BSBR) which fell 4.75% but saw 100% buy orders and a shorter typical hold time of 5 days. Aon PLC (AON) gained 4.59% despite 93% sell orders and a notably longer typical hold time of 124 days.
On National First Responders Day, ADT celebrated local first responders and its monitoring professionals by unveiling a renovated monitoring center in Irving, Texas, part of a $2 million investment. The upgraded center features enhanced equipment and...
Cobalt Boats unveiled the 2027 265 Coastal Edition, a fully redesigned luxury outboard runabout tailored for coastal boating enthusiasts. Featuring wood-free construction, enhanced comfort, and advanced technology like dual 9-inch displays and option...
Presidio was named Enterprise Partner of the Year and Software and Services Partner of the Year for the Americas at the Cisco Partner Summit 2026. These awards recognize partners who excel in service and innovation, helping customers succeed through ...
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including derma...
